- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
Lilly Makes Its Fifth Acquisition of 2026 — That's Nearly $20B in Deals in Three Months
Ajax Therapeutics brings a first-in-class blood cancer drug to Lilly's expanding oncology pipeline. Meanwhile, Regeneron became the last of 17 pharma companies to sign an MFN deal. All 17 are now in. Lilly reports earnings tomorrow.
Видео Lilly Makes Its Fifth Acquisition of 2026 — That's Nearly $20B in Deals in Three Months канала BioMed Nexus
Видео Lilly Makes Its Fifth Acquisition of 2026 — That's Nearly $20B in Deals in Three Months канала BioMed Nexus
Комментарии отсутствуют
Информация о видео
28 апреля 2026 г. 14:18:35
00:18:20
Другие видео канала
The Wegovy Pill Just Doubled Expectations: Why Novo Nordisk is Winning the Weight Loss War
Biotech Market Outlook Q1 2026: Top 7 Picks & Capital Rotation Strategy
The Iran War Is Now Hitting Pharma Supply Chains Directly
Lilly's Next Obesity Drug Just Matched Bariatric Surgery in a Phase 3 Trial
Top 6 Biotech Stocks to Watch THIS WEEK (JPM 2026 Insider Playbook)
![20 Biotech Startups to Watch in 2026: AI, Gene Editing & Obesity [The Full List]](https://i.ytimg.com/vi/fKg_URyFWrk/default.jpg)
20 Biotech Startups to Watch in 2026: AI, Gene Editing & Obesity [The Full List]
GSK’s $950M PAH Bet: 35Pharma Deal Signals Activin Race
Q1 2026 Biotech Outlook AI Deep Dive & Stock Analysis
UNH Crashes 20%: The End of Managed Care’s Golden Era? (+ Intellia & Sarepta Wins)
Future of Medicine 2026: Full Breakdown of 20 Biotech Startups (AI, Obesity, CRISPR)
The End of Cancer? The $50 Blood Test & The Great Medical Shift
23% Weight Loss Data Revealed! Is Kailera (KAI-9531) the New Wegovy Killer?
The ASCO Plenary Changed Three Treatment Standards in a Single Afternoon
FDA Signals Shift to Single-Trial Standard | Insmed Guides to $1B | Madrigal Nears Blockbuster
PhRMA's Longest-Serving CEO Is Stepping Down • FDA Proposes a Faster Path to Phase 1
Lilly–Innovent Partnership, Takeda’s AI Strategy, J&J Recall
Four FDA Approvals in One Week • Novartis Drops $3B • The Obesity War Just Got a New Front
BridgeBio Phase 3 Win • FDA HRT Label Shift • Universal Flu Trial
FDA Approves Bysanti | The Single-Trial Era Begins
Japan Approves First iPS Therapies • Xenon’s Record Epilepsy Data • FDA Eases Biosimilar Path
